NFE2L2 and Alzheimer disease: Therefore, Nrf2 activation is a potential therapeutic target for various diseases, associated with OS, including neurodegenerative diseases such as AD and Parkinson’s disease, as well as cancer, diabetes and cardiovascular diseases [28,29].